Browsing by Author Bowtell, David D L

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)Citation
2012BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupdeFazio, Anna; Emmanuel, Catherine; Alsop, Kathryn; Birrer, Michael; Bowtell, David D L; Dobrovic, Alexander; Fereday, Sian; Fox, Stephen B.; Friedlander, Michael; George, Joshy; Meldrum, Cliff; Mitchell, Gillian; Stewart, Colin; Webb, Penelope M.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstituteBRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, Journal of Clinical Oncology, vol.30, 21, 2012,pp 2654-2663
2010Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.deFazio, Anna; Sharma, Raghwa; Ahmed Ashoure, Ahmed; Bowtell, David D L; Brenton, James D; Caldas, Carlos; Etemadmoghadam, Dariush; Fereday, Sian; Lynch, Andy; Riad, Mohamed; Stewart, Colin L.; Temple, Jillian; Western Clinical School: Westmead Millennium Institute; MedicineDriver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary., Journal of Pathology, vol.221, 1,pp 49-56
2014Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studydeFazio, Anna; Madore, Jason; Bowtell, David D L; Clarke, B; Deen, Suha; et al, Various; Kobel, M; Lele, S; Menon, U; Morrison, C; Odunsi, Kunle; Pharoah, Paul D. P.; Ramus, Susan J.; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Melonoma & Skin Cancer Res. Inst.Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study, British Journal of Cancer, vol.111, 12, 2014,pp 2297-2307
2013High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better SurvivaldeFazio, Anna; Alsop, Kathryn; Børresen-Dale, Anne Lise; Baumbusch, Lars; Bowtell, David D L; Brown, Pat; Etemadmoghadam, Dariush; Fereday, Sian; Helland, Aslaug; Holm, Ruth; Kristensen, Gunnar; Liestöl, Knut; Lingjærde, Ole Christian; Mitchell, Gillian; Schaner, Marci; Wang, Yun; Western Clinical School: Westmead Millennium InstituteHigh Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival, PLoS One, vol.8, 1, 2013,pp 1-8
2007High resolution melting for mutation scanning of TP53 exons 5-8deFazio, Anna; Ahmed Ashoure, Ahmed; Bowtell, David D L; Brenton, James D; Dobrovic, Alexander; Etemadmoghadam, Dariush; Fox, Stephen B; Hyland, Sarah; Krypuy, Michael; Western Clinical School: Westmead Millennium InstituteHigh resolution melting for mutation scanning of TP53 exons 5-8, BMC Cancer, vol.7,(open access),2007,pp 168-N/A
2011IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell CancerdeFazio, Anna; Anglesio, Michael S.; Australian Ovarian Cancer Study Group, (AOCSG); Balkwill, Frances; Birrer, Michael J.; Bowtell, David D L; Campbell, Ian G.; Chakravarty, Probir; Coward, Jermaine; Cowin, Prue; Friedlander, Michael L.; George, Joshy; Gilks, B; Gorringe, Kylie; House, Colin; Huntsman, David; Kalloger, Steve; Kulbe, Hagen; Lemech, Charlotte; Okamoto, Aikou; Power, Jeremy; Rischin, D.; Western Clinical School: Westmead Millennium InstituteIL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer, Clinical Cancer Research, vol.17, 8, 2011,pp 2538-2548
2008Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.deFazio, Anna; Russell, Peter; Anglesio, Michael S.; Arnold, Jeremy; Australian Ovarian Cancer Study Group, (AOCSG); Birrer, Michael J.; Bowtell, David D L; Chenevix-Trench, Georgia; Fereday, Sian; George, Joshy; Locandro, Bianca; Sharma, Raghwa; Simms, Lisa; Tinker, A. V.; Tothill, Richard W.; Traficante, Nadia; Waddell, Nic; Western Clinical School: Westmead Millennium Institute; Central Clinical School: PathologyMutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors., Molecular Cancer Research, vol.6, 11, 2008,pp 1678-1690
2017A Myc activity signature predicts poor clinical outcomes in Myc-associated cancersdeFazio, Anna; Bowtell, David D L; et al, Various; George, Joshy; Jung, MoonSun; Liu, Bing; Liu, Pei Yan; Liu, Tao; London, Wendy; Oberthuer, Andre; Russell, Amanda; Western Clinical School: Westmead Institute for Medical ResA Myc activity signature predicts poor clinical outcomes in Myc-associated cancers, Cancer Research, vol.77, 4, 2017,pp 971-981
2013Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutationsdeFazio, Anna; Alsop, Kathryn; Bowtell, David D L; Dobrovic, Alexander; Etemadmoghadam, Dariush; George, Joshy; Hondow, Heather; Levine, Douglas; Mikeska, Thomas; Mitchell, Gillian; Smyth, Gordon; Western Clinical School: Westmead Millennium InstituteNonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations, Clinical Cancer Research, vol.19, 13, 2013,pp 3474-3484
2008Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.deFazio, Anna; Australian Ovarian Cancer Study Group, (AOCSG); Bowtell, David D L; Brown, Robert; Chiew, Yoke-Eng; Etemadmoghadam, Dariush; Fereday, Sian; Fox, Stephen B.; George, Joshy; Gertig, Dorota; Haviv, Izhak; Hung, Jillian A.; Johnson,, Daryl S.; Lade, Stephen; Locandro, Bianca; Tinker, Anna V.; Tothill, Richard W.; Traficante, Nadia; Trivett, Melanie K.; Western Clinical School: Westmead Millennium InstituteNovel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome., Clinical Cancer Research, vol.14, 16, 2008,pp 5198-5208
2014Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancerBalleine, Rosemary; deFazio, Anna; Emmanuel, Catherine; Gao, Bo-Fu; Harnett, Paul; Wong, Ka (Mark); Beesley, Jonathan; Bowtell, David D L; Chen, Xiao Qinq; Chenevix-Trench, Georgia; Galletta, Laura; Haber, Michelle; Healey, Sue; Henderson, Michelle; Johnatty, Sharon E.; Norris, Murray D.; Russell, Amanda; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer, Scientific Reports, vol.4, N/A, 2014,pp 1-9
2011Reducing Time to Diagnosis Does Not Improve Outcomes for Women With Symptomatic Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupdeFazio, Anna; Bowtell, David D L; Fereday, Sian; Francis, Jane E.; Green, Adele C.; Luxford, Karen; Nagle, Christina M.; Nelson, Anne E.; Webb, Penelope M.; Zorbas, Helen; Western Clinical School: Westmead Millennium InstituteReducing Time to Diagnosis Does Not Improve Outcomes for Women With Symptomatic Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group, Journal of Clinical Oncology, vol.29, 16, 2011,pp 2253-2258
2016The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancerClarkson, Adele; Clifton-Bligh, Roderick; Cole, Alexander J; deFazio, Anna; Dickson, Kristie-Ann; Gill, Anthony; Henderson, Beric; Kennedy, Catherine Jane; Marsh, Deborah; Alsop, Kathryn; Bowtell, David D L; Chou, Angela; Fereday, Sian; Gard, Gregory; Traficante, Nadia; Northern Clinical School: Pathology; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; Western Clinical School: Westmead Institute for Medical Res; Northern Clinical School: Medicine; Northern Clinical School: Pathology; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Obstetrics & Gynaecology; Northern Clinical School: Kolling InstituteThe RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer, Human Molecular Genetics, vol.25, 24, 2016,pp 5460-5471
2002Siah ubiquitin ligase structurally related to TRAF and modulates TNF-a signalingMackay, Joel; Bowtell, David D L; House, Colin M; Parker, Michael W; Polekhina, Galina; Relaix, Frederic; Sassoon, David A; Traficante, Nadia; Molecular & Microbial BioscienSiah ubiquitin ligase structurally related to TRAF and modulates TNF-a signaling, Nature Structural and Molecular Biology, vol.9,(1),2002,pp 68-75